Hydroxyurea derivatives kill colon cancer cells

by Medindia Content Team on  November 9, 2001 at 12:17 PM General Health News
RSS Email Print This Page Comment
Hydroxyurea derivatives kill colon cancer cells
A new class of drugs based on a widely used anticancer drug, hydroxyurea, shows potent colon cancer-killing effects in the laboratory and in mice, according to researchers. The new compounds seem to be very interesting for the treatment of these tumors.
Advertisement

Previous drugs derived from hydroxyurea were extremely active in blocking the same cell targets as hydroxyurea, but had serious side effects. This prompted the researchers to synthesize similar drugs with different structures that they hypothesized would be less likely to cause complications.

Advertisement
The researchers tested the drugs against colon cancer implants in mice. One of the compounds, EPH116, blocked the tumor growth at doses that did not appear toxic. EPH116 brought considerable cancer cell death, but did so by as yet unknown mechanisms. In the laboratory, EPH116 and its relatives also showed activity against small cell lung cancer and malignant melanoma cells.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Cancer and Homeopathy Parkinsons Disease Surgical Treatment Colo-rectal cancer - Management Colorectal Cancer Cancer Facts Cancer Colon Crohns Disease Diverticulosis and Diverticulitis Colon Polyps 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive